C WorldWide Group Holding A S lessened its holdings in shares of McKesson Co. (NYSE:MCK – Free Report) by 18.4% in the fourth quarter, Holdings Channel reports. The firm owned 3,536 shares of the company’s stock after selling 796 shares during the period. C WorldWide Group Holding A S’s holdings in McKesson were worth $2,015,000 at the end of the most recent quarter.
Several other large investors also recently bought and sold shares of the company. Union Bancaire Privee UBP SA purchased a new position in shares of McKesson during the 4th quarter valued at approximately $3,069,000. Howard Capital Management Inc. lifted its stake in McKesson by 4.6% in the fourth quarter. Howard Capital Management Inc. now owns 888 shares of the company’s stock valued at $506,000 after buying an additional 39 shares during the last quarter. Fisher Funds Management LTD bought a new stake in McKesson in the fourth quarter valued at $8,295,000. Pinnacle Financial Partners Inc lifted its stake in McKesson by 9.1% in the fourth quarter. Pinnacle Financial Partners Inc now owns 2,075 shares of the company’s stock valued at $1,183,000 after buying an additional 173 shares during the last quarter. Finally, Redmond Asset Management LLC bought a new stake in McKesson in the fourth quarter valued at $470,000. Institutional investors and hedge funds own 85.07% of the company’s stock.
Insiders Place Their Bets
In related news, CEO Brian S. Tyler sold 8,961 shares of the company’s stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $600.66, for a total value of $5,382,514.26. Following the completion of the sale, the chief executive officer now owns 69,625 shares in the company, valued at approximately $41,820,952.50. This represents a 11.40 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Leann B. Smith sold 579 shares of the stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $572.79, for a total value of $331,645.41. Following the completion of the sale, the executive vice president now owns 864 shares of the company’s stock, valued at $494,890.56. This trade represents a 40.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 10,307 shares of company stock valued at $6,177,790. 0.11% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes
McKesson Trading Down 1.0 %
MCK opened at $597.68 on Monday. The stock’s 50 day simple moving average is $589.02 and its 200-day simple moving average is $561.62. The stock has a market cap of $74.91 billion, a PE ratio of 27.37, a P/E/G ratio of 1.29 and a beta of 0.52. McKesson Co. has a 1 year low of $464.42 and a 1 year high of $637.51.
McKesson (NYSE:MCK – Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $8.03 EPS for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. Equities analysts forecast that McKesson Co. will post 32.77 earnings per share for the current fiscal year.
McKesson Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 1st. Shareholders of record on Monday, March 3rd will be paid a $0.71 dividend. This represents a $2.84 dividend on an annualized basis and a yield of 0.48%. The ex-dividend date of this dividend is Monday, March 3rd. McKesson’s dividend payout ratio is currently 13.00%.
McKesson Profile
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
See Also
- Five stocks we like better than McKesson
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- What Are Treasury Bonds?
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- Utilities Stocks Explained – How and Why to Invest in Utilities
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.